ClosedNo longer accepting applications
A--To Expand the Workscope of the PACT III Program
U.S. General Services Administration (SAM.gov)
About this archived opportunity
The primary purpose of the acquisition for the Production Assistance for Cellular Therapy (PACT) III program contract awards is to expand the scope of the program by reintroducing the manufacture and distribution of cellular products for use in human subjects participating in clinical trials under investigational new drug (IND) applications for the cell product.
Historical details
- Status
- Closed
- First captured
- January 11, 2026
- Publisher reference
- a5e827f73313b45eea3e2ec1d0d6d0e5
Eligibility: Women-Owned Small Business. WOSB
This opportunity has closed
A--To Expand the Workscope of the PACT III Program
by U.S. General Services Administration (SAM.gov)
Get notified when similar opportunities open
We'll save this search and email you when new expand, workscope opportunities are posted. Free.
Related opportunities
- BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EBDEPT OF DEFENSECloses Jun 2027
- BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1DEPT OF DEFENSECloses Aug 2028
- BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development - HT9425-23-S-SOC1DEPT OF DEFENSECloses Aug 2028
- Generally Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partnersDEPT OF DEFENSECloses Oct 2028
- JPEO-CBRND CWMD BOTAA-24-01DEPT OF DEFENSECloses Feb 2029